The current status of trademark application 6505356 for DAWNZERA is Accepted & Advertised.
The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.
| Application Number | 6505356 |
| Trademark Status | Accepted & Advertised |
| Trademark Class | 99 |
| Application Date | 2023-11-28 |
| Proprietor Name | Ionis Pharmaceuticals, Inc. |
| Appropriate Office | IR DIVISION |
| State | STATE NOT SPECIFIED |
| Trademark Type | WORD |
| User Details | Proposed to be used |
| Goods And Services Details | [CLASS : 5] Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceuticals in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders.[CLASS : 42] Pharmaceutical research and development in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; providing medical and scientific research and medical and scientific research information in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; providing information and data in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders for medical and scientific research purposes. |
Similar trademarks found for this brand
| Brand | Class | Status |
|---|---|---|
| DAWNZERA | 99 | Accepted & Advertised |
Common questions about DAWNZERA.